Title: Maite Agueros Bazo: Innovator in Microparticle Technology
Introduction
Maite Agueros Bazo is a notable inventor based in Spain, recognized for her contributions to the field of microparticle technology. With a focus on encapsulating probiotics and biologically active compounds, her work has significant implications for the food, pharmaceutical, and cosmetic sectors. Although she currently holds no patents, her innovative ideas are paving the way for future advancements.
Latest Patents
Maite Agueros Bazo's latest inventions include two significant patents. The first is titled "Microparticles For Encapsulating Probiotics, Obtaining Said Microparticles And Uses Thereof." This invention involves microparticles that consist of a matrix made from casein and chitosan, which protects probiotic bacteria during processing, storage, and transit through the gastrointestinal tract, thereby extending their useful life. The second patent is "Zein Nanoparticles For Encapsulation Of Compounds, The Production And Uses Thereof." This invention focuses on nanoparticles that encapsulate both water-soluble and fat-soluble biologically active compounds, utilizing a zein matrix and a basic amino acid. These nanoparticles have applications across various sectors, including food, pharmaceuticals, cosmetics, and nanotechnology.
Career Highlights
Throughout her career, Maite has worked with several esteemed organizations. She has been associated with the National Center for Food Technology and Safety, Ebro Laboratory, and the University of Navarra. Her experience in these institutions has allowed her to develop her expertise in the field of microparticle technology.
Collaborations
Maite has collaborated with notable colleagues, including Irene Esparza Catalan and Carolina Gonzalez Ferrero. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Maite Agueros Bazo is an emerging inventor whose work in microparticle technology holds promise for various industries. Her innovative approaches to encapsulating probiotics and biologically active compounds are set to make a significant impact in the future.